Dr. Maller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Dna Way
South San Francisco, CA 94080
Summary
- Late-stage clinical development at Genentech in the Rheumatology & Renal franchise
Education & Training
- Kaiser Permanente Northern CaliforniaResidency, Pediatrics, 2014 - 2017
- University of Colorado School of Medicine Anschutz Medical CampusClass of 2014, MD
- University of Colorado - Anschutz Medical CampusPhD, Molecular Biology, NIH Medical Scientist Training Program, 2007 - 2012
- University of California, BerkeleyBA, Molecular Biology, neuroscience emphasis; Minor in Rhetoric, 2001 - 2005
Certifications & Licensure
- CA State Medical License 2015 - 2025
Publications & Presentations
PubMed
- 45 citationsInhibition of MerTK increases chemosensitivity and decreases oncogenic potential in T-cell acute lymphoblastic leukemiaLuis Brandao, A Winges, Sandra Christoph, Susan Sather, Justine Migdall-Wilson
Blood Cancer Journal. 2013-01-25 - 162 citationsMer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer.Rachel M. A. Linger, Rebecca A. Cohen, Christopher T. Cummings, Susan Sather, Justine Migdall-Wilson
Oncogene. 2013-07-18 - 29 citationsProlonged Exposure to a Mer Ligand in Leukemia: Gas6 Favors Expression of a Partial Mer Glycoform and Reveals a Novel Role for Mer in the NucleusJustine Migdall-Wilson, Christine Bates, Jennifer Schlegel, Luis Brandao, Rachel M. A. Linger
Plos One. 2012-02-20
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: